Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cole

Showing results (471-480 of 503) with videos related to

Pageof 51
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Breast Cancer Research and Treatment|December 6, 2013
Symptoms of endocrine treatment and outcome in the BIG 1-98 studyJ Huober, B F Cole, M Rabaglio, et al.
Gastroenterology|February 22, 2017
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on OutcomeJoseph C Anderson, John A Baron, Dennis J Ahnen, et al.
The Lancet. Oncology|August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer NetworkAurelius Omlin, Maurizio Amichetti, David Azria, et al.
Nature|January 22, 2010
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screenFrédéric Bienvenu, Siwanon Jirawatnotai, Joshua E Elias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerPer Karlsson, Bernard F Cole, Karen N Price, et al.
Journal of Thoracic Disease|August 23, 2021
A simple assessment of lung nodule location for reduction in unnecessary invasive proceduresC Matthew Kinsey, Ehab Billatos, Vitor Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trialRichard D Gelber, Xin V Wang, Bernard F Cole, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
Cancer|December 8, 2020
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trialJose P Leone, Bernard F Cole, Meredith M Regan, et al.
Pageof 51

Showing results (471-480 of 503) with videos related to

Sort By:
Pageof 51
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Breast Cancer Research and Treatment|December 6, 2013
Symptoms of endocrine treatment and outcome in the BIG 1-98 studyJ Huober, B F Cole, M Rabaglio, et al.
Gastroenterology|February 22, 2017
Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on OutcomeJoseph C Anderson, John A Baron, Dennis J Ahnen, et al.
The Lancet. Oncology|August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer NetworkAurelius Omlin, Maurizio Amichetti, David Azria, et al.
Nature|January 22, 2010
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screenFrédéric Bienvenu, Siwanon Jirawatnotai, Joshua E Elias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerPer Karlsson, Bernard F Cole, Karen N Price, et al.
Journal of Thoracic Disease|August 23, 2021
A simple assessment of lung nodule location for reduction in unnecessary invasive proceduresC Matthew Kinsey, Ehab Billatos, Vitor Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trialRichard D Gelber, Xin V Wang, Bernard F Cole, et al.
Annals of Surgical Oncology|October 28, 2005
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinomaJ Marc Pipas, Richard J Barth, Bassem Zaki, et al.
Cancer|December 8, 2020
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trialJose P Leone, Bernard F Cole, Meredith M Regan, et al.
Pageof 51